AlloMend tissue support in breast reconstruction after mastectomy
Part of Cancer, Skin clinical trials.
This study tests a special tissue support called AlloMend used during breast reconstruction after mastectomy. It helps see how well the tissue works and how patients heal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to have a mastectomy (removal of one or both breasts) and then get breast reconstruction that uses a special tissue support called AlloMend.
- Your surgeon will be using the AlloMend® Acellular Dermal Matrix (a type of donated human tissue graft) during your reconstruction.
- You can attend follow-up visits at 2 weeks, 6 weeks, 3 months, and 6 months after your surgery.
- Your post-surgery check-ups will be done at the same clinic or hospital where the study takes place.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special supportive material called acellular dermal matrix in women having two-stage breast reconstruction after mastectomy. The goal is to learn how well it works when the implant is placed directly under the skin, over the chest muscle.
This trial tests a new acellular matrix (a material made from natural tissue) used during breast reconstruction with implants. It aims to help support the implant and promote natural tissue healing.
This trial studies whether a lab-made skin graft (called ADM) used with tissue expanders can improve breast reconstruction after mastectomy. It may help people who are planning a specific two-step implant reconstruction approach.
This study tests whether using surgical mesh can be done safely and works well in breast reconstruction done right away, in front of the chest muscle (pre-pectoral) using tissue expanders. It may help improve how the reconstructed area holds up, but you’d need to meet specific surgical and health requirements.
This trial tests a new mesh-like device called Melodi Matrix to support breast reconstruction after mastectomy. It may help women who are planning immediate two-stage implant reconstruction after removing one or both breasts.
This trial tests a special tissue matrix used during breast-conserving surgery to help support the breast. It may help improve cosmetic outcomes after lumpectomy for breast cancer patients.
Hear when a new Pre-Pectoral Breast Reconstruction Following Single or Double Mastectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.